US Patent 10279039 Agonist antibodies that bind human CD137 and uses thereof
Patent 10279039 was granted and assigned to Compass Therapeutics Llc on May, 2019 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10279039 Agonist antibodies that bind human CD137 and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
